UK genetic discovery programme for eight major diseases gets £9m boost:
This article was originally published in Clinica
UK researchers have received a £9m ($15.8) grant to begin a nationwide study to identify genetic variants that might predispose people to eight major diseases. The three-year project, which has received funding from the Wellcome Trust, will analyse and identify genetic markers for tuberculosis, coronary heart disease, type-1 and type-2 diabetes, rheumatoid arthritis, Crohn's disease, bipolar disorder and hypertension. Researchers from the Wellcome Trust Case Control Consortium (WTCCC) - a collaboration of 24 leading human geneticists - will analyse over 19,000 DNA samples for 675,00 genetics points where key variations are thought to occur. The study will be conducted at various institutes and universities throughout the UK, including the Wellcome Trust Sanger Institute, Cambridge University and Oxford University.
You may also be interested in...
A combined final opinion on the European Chemicals Agency’s proposed microplastic restriction is expected from ECHA committees by year-end, at which point the European Commission will consider whether and when microplastic must be removed from all leave-on cosmetic products marketed in the EU.
Butterfly Network’s CEO Laurent Faracci outlines the company’s growth strategy and plans for their “ultrasound-on-a-chip” technology after its merger with blank check company Longview Acquisition Corp. See what the company’s CEO said about it here.
CDC’s Advisory Committee on Immunization Practices votes 13-1 that these two groups be first in line for vaccination once FDA authorizes a vaccine and ACIP recommends it. Goal of vote is to guide health departments in placing vaccine orders.